As of May 22
| +0.01 / +0.32%|
The 6 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 4.50, with a high estimate of 7.50 and a low estimate of 2.00. The median estimate represents a +42.86% increase from the last price of 3.15.
The current consensus among 6 polled investment analysts is to Hold stock in Solazyme Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.